NCT01548430View on ClinicalTrials.gov

A Safety Study of TTP4000 in Subjects With Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Alzheimer's Disease

Interventions

DRUG

TTP4000

DRUG

Placebo

Trial Locations (3)

Unknown

Miami

Durham

High Point

Sponsors

Lead Sponsor

vTv Therapeutics

All Listed Sponsors

lead

vTv Therapeutics

INDUSTRY